After brutal slaughter the market ended with some gains on Thursday. The Sensex was up 516.53 points or 2 percent at 26231.1 and the Nifty gained157.10 points or 2 percent at 7948.95. About 1993 shares advanced, 689 shares declined, and 96 shares were unchanged.
Posts tagged MC
Sensex, Nifty end 2% higher but worst Aug series in 2 years (27-08-2015)
Hold Hindustan Zinc; target of Rs 140: ICICIdirect (27-08-2015)
ICICIdirect.com has recommended to hold Hindustan Zinc with a target price of Rs 140, in its research report dated August 27, 2015.
Buy Jagran Prakashan; target of Rs 158: Karvy (27-08-2015)
Karvy Stock Broking is bullish on Jagran Prakashan and has recommended buy rating on the stock with a target price of Rs 158, in its research report dated August 27, 2015.
Buy Panasonic Carbon; target of Rs 600: Firstcall (27-08-2015)
Brokerage house Firstcall Research is bullish on Panasonic Carbon India and has recommended buy rating on the stock with a target price of Rs 600 in its research report dated August 26, 2015.
Buy Bharat Forge; target Rs 1294: ICICIdirect (27-08-2015)
ICICIdirect.com is bullish on Bharat Forge and has recommended buy rating on the stock with a target price of Rs 1294, in its research report dated August 26, 2015.
Buy NBCC; target of Rs 1250: Karvy (27-08-2015)
Karvy Stock Broking is bullish on National Buildings Construction Corporation (NBCC) and has recommended buy rating on the stock with a target price of Rs 1250, in its research report dated August 27, 2015.
Buy TTK Healthcare; target of Rs 1095: Firstcall (27-08-2015)
Brokerage house Firstcall Research is bullish on TTK Healthcare and has recommended buy rating on the stock with a target price of Rs 1095 in its research report dated August 26, 2015.
Buy Mindtree; target Rs 1450: ICICIdirect (27-08-2015)
ICICIdirect.com is bullish on Mindtree and has recommended buy rating on the stock with a target price of Rs 1450, in its research report dated August 26, 2015.
Aurobindo gets USFDA nod for hepatitis B drug (27-08-2015)
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Entecavir tablets in strengths of 0.5mg and 1mg, Aurobindo Pharma said in a statement.
Smart cities need more funds, longer timeline: Infra sector (27-08-2015)
Speaking to CNBC-TV18, YD Murthy, Executive Vice President-Finance, NCC Limited says that he is confident of getting substantial orders for the smart city project and is looking forward to the new capital city of Amravati.